Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.30% rose 1.82% to $168.98 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.15% rising 0.75% to 4,352.34 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% rising 0.44% to 34,786.35. This was the stock's fourth consecutive day of gains. Johnson & Johnson closed $4.67 short of its 52-week high ($173.65), which the company reached on January 26th.
The stock outperformed some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -0.80% rose 0.22% to $379.80, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.77% rose 0.78% to $78.60, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.57% rose 0.43% to $39.73. Trading volume (9.1 M) eclipsed its 50-day average volume of 6.7 M.